Jason Kelly | search
Click here to view Jason Kelly news from 60+ newspapers.
Bookmark or Share- Is Ginkgo’s synthetic-biology story worth $15 billion?August 24, 2021. Mz Tech. The Boston genetic engineering company Ginkgo Bioworks and its CEO, Jason Kelly, have been spectacularly successful selling a story: that synthetic biology will...
- Ginkgo's Jason Kelly is chairing a federal biotech advisory group - STATGet Started. Jason Kelly will chair the commission while heading Ginkgo, with a roughly 6% stake in the company currently valued at over $100 million.
- Jason Kelly - Cambridge, Massachusetts, United States - LinkedInLocation: Cambridge · 500+ connections on LinkedIn. View Jason Kelly’s profile on LinkedIn, a professional community of 1 billion members.
- About - Ginkgo BioworksJason Kelly is the co-founder and CEO of Ginkgo Bioworks. He has served as a member of our board of directors since Ginkgo’s founding in 2008. He has also served as a director of CM Life Sciences II Inc. (Nasdaq: CMII), a special purpose acquisition company with a focus on the life sciences sector, since its initial public offering in ...
- Ginkgo Bioworks To Go Public In $17.5 Billion Deal With Former ... - Forbes“It’s a really fun time now, actually,” says Ginkgo cofounder and CEO Jason Kelly. “Covid-19 has had a weird effect on biology awareness. Proteins are on the cover of The New York Times.
More
